Xlumena Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $80M

Xlumena General Information

Description

Developer of image-guided therapeutic endoscopy products. The company develops products that enable advanced image-guided endoscopy procedures to allow endoscopists to offer minimally invasive alternatives to patients suffering from common gastrointestinal and biliary conditions.

Contact Information

Website
www.xlumena.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 453 Ravendale Drive
  • Suite H
  • Mountain View, CA 94043
  • United States
+1 (650)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Boston Scientific
Vertical(s)
Corporate Office
  • 453 Ravendale Drive
  • Suite H
  • Mountain View, CA 94043
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xlumena Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 02-Apr-2015 $80M Completed Generating Revenue
5. Later Stage VC (Series C) 03-Dec-2013 Completed Startup
4. Later Stage VC (Series B) 04-Oct-2013 Completed Startup
3. Early Stage VC (Series B) 21-Aug-2012 Completed Startup
2. Early Stage VC (Series B) 28-Apr-2011 $7M $13.1M Completed Startup
1. Early Stage VC (Series A) 21-May-2008 $6.15M $6.15M Completed Startup
To view Xlumena’s complete valuation and funding history, request access »

Xlumena Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2
Series C1
Series B 15,500,000 $0.001000 $0.04 $0.62 $0.62 1x $0.62 13.85%
Series A 19,991,930 $0.001000 $0.04 $0.62 $0.62 1x $0.62 17.86%
To view Xlumena’s complete cap table history, request access »

Xlumena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of image-guided therapeutic endoscopy products. The company develops products that enable advanced image-guide
Therapeutic Devices
Mountain View, CA
16 As of 2014

Danvers, MA
 

Tirat Carmel, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xlumena Competitors (29)

One of Xlumena’s 29 competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abiomed Corporate Backed or Acquired Danvers, MA
Insightec Venture Capital-Backed Tirat Carmel, Israel
Boston Scientific Corporation Marlborough, MA
Morphic Medical Private Equity-Backed Boston, MA
Endologix Corporation Santa Rosa, CA
You’re viewing 5 of 29 competitors. Get the full list »

Xlumena Patents

Xlumena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2946789-A1 Biliary stent Inactive 18-Jun-2014
WO-2015195893-A1 Biliary stent Inactive 18-Jun-2014
US-10722341-B2 Biliary stents and methods Active 18-Jun-2014
US-20160135941-A1 Biliary stents and methods Inactive 18-Jun-2014
US-20180289463-A1 Biliary stents and methods Active 18-Jun-2014 A61F2/04
To view Xlumena’s complete patent history, request access »

Xlumena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xlumena Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATEL Capital Group Asset Manager Minority
Aperture Venture Partners Venture Capital Minority
Ascent Biomedical Ventures Venture Capital Minority
Charter Life Sciences Venture Capital Minority
Prism Venture Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Xlumena FAQs

  • When was Xlumena founded?

    Xlumena was founded in 2008.

  • Where is Xlumena headquartered?

    Xlumena is headquartered in Mountain View, CA.

  • What is the size of Xlumena?

    Xlumena has 16 total employees.

  • What industry is Xlumena in?

    Xlumena’s primary industry is Therapeutic Devices.

  • Is Xlumena a private or public company?

    Xlumena is a Private company.

  • What is the current valuation of Xlumena?

    The current valuation of Xlumena is .

  • What is Xlumena’s current revenue?

    The current revenue for Xlumena is .

  • How much funding has Xlumena raised over time?

    Xlumena has raised $50.1M.

  • Who are Xlumena’s investors?

    ATEL Capital Group, Aperture Venture Partners, Ascent Biomedical Ventures, Charter Life Sciences, and Prism Venture Management are 5 of 7 investors who have invested in Xlumena.

  • Who are Xlumena’s competitors?

    Abiomed, Insightec, Boston Scientific, Morphic Medical, and Endologix are some of the 29 competitors of Xlumena.

  • When was Xlumena acquired?

    Xlumena was acquired on 02-Apr-2015.

  • Who acquired Xlumena?

    Xlumena was acquired by Boston Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process